These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35816945)

  • 21. Longitudinal changes of laboratory measurements after discharged from hospital in 268 COVID-19 pneumonia patients.
    Huang D; Miao H; Zhang Z; Yang Y; Zhang L; Lure FYM; Wang Z; Jaeger S; Guo L; Xu T; Liu J
    J Xray Sci Technol; 2021; 29(5):741-762. PubMed ID: 34397444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in Patients with COVID-19.
    Pan F; Yang L; Liang B; Ye T; Li L; Li L; Liu D; Wang J; Hesketh RL; Zheng C
    Radiology; 2022 Mar; 302(3):709-719. PubMed ID: 34609153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
    Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
    J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19.
    Liao B; Liu Z; Tang L; Li L; Gan Q; Shi H; Jiao Q; Guan Y; Xie M; He X; Zhao H; Chen W; Liu Y; Li L; Wang Y; Cao Y; Shi Y; Li Y; Lei C
    Int J Med Sci; 2021; 18(1):29-41. PubMed ID: 33390771
    [No Abstract]   [Full Text] [Related]  

  • 25. Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study.
    Huang S; Zhou X; Zhao W; Du Y; Yang D; Huang Y; Chen Y; Zhang H; Yang G; Liu J; Luo H
    Theranostics; 2023; 13(2):724-735. PubMed ID: 36632218
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of Chest CT Results of Coronavirus Disease 2019 (COVID-19) Patients at First Follow-Up.
    Zhong L; Zhang S; Wang J; Zhao X; Wang K; Ding W; Xing Z; Shen J
    Can Respir J; 2020; 2020():5328267. PubMed ID: 33204376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory response in lungs and extrapulmonary sites detected by [
    Bai Y; Xu J; Chen L; Fu C; Kang Y; Zhang W; Fakhri GE; Gu J; Shao F; Wang M
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2531-2542. PubMed ID: 33420914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection.
    Smet J; Stylemans D; Hanon S; Ilsen B; Verbanck S; Vanderhelst E
    Respir Med; 2021 Jan; 176():106276. PubMed ID: 33278758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 31. Pediatric cervical kyphosis in the MRI era (1984-2008) with long-term follow up: literature review.
    Menezes AH; Traynelis VC
    Childs Nerv Syst; 2022 Feb; 38(2):361-377. PubMed ID: 34806157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation.
    Ruan Y; Hu B; Liu Z; Liu K; Jiang H; Li H; Li R; Luan Y; Liu X; Yu G; Xu S; Yuan X; Wang S; Yang W; Ye Z; Liu J; Wang T
    Andrology; 2021 Jan; 9(1):99-106. PubMed ID: 33150723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.
    Zhou M; Xu J; Liao T; Yin Z; Yang F; Wang K; Wang Z; Yang D; Wang S; Peng Y; Peng S; Wu F; Chen L; Jin Y
    Front Med (Lausanne); 2021; 8():682087. PubMed ID: 34249973
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary fibrotic-like changes on follow-up chest CT exam in patients recovering from COVID-19 pneumonia.
    Vural A; Kahraman AN
    Tuberk Toraks; 2021 Dec; 69(4):492-498. PubMed ID: 34957743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial.
    Sonnweber T; Tymoszuk P; Sahanic S; Boehm A; Pizzini A; Luger A; Schwabl C; Nairz M; Grubwieser P; Kurz K; Koppelstätter S; Aichner M; Puchner B; Egger A; Hoermann G; Wöll E; Weiss G; Widmann G; Tancevski I; Löffler-Ragg J
    Elife; 2022 Feb; 11():. PubMed ID: 35131031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Mangoni AA
    Front Immunol; 2021; 12():696085. PubMed ID: 34163491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.